CDXS
CODEXIS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.32
+6.45%Sep 28, 2026, 10:00 UTC
Codexis Inc. announced an agreement with an unnamed pioneering siRNA drug innovator to explore stereo-defined fragment synthesis using its ECO Synthesis Manufacturing Platform.
Source:Aug 11, 2026, 20:05 UTC
Codexis reported financial results for the second quarter ended June 30, 2026, with revenue of $14.9 million.
Aug 11, 2026, 20:05 UTC
Codexis completed an equity capital raise with approximately $25 million in net proceeds.
Source:Jul 23, 2026, 20:13 UTC
Codexis announced a proposed underwritten public offering of shares of its common stock.